Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3126last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Financial Times95d agobullish
Eli Lilly and Novo Nordisk raise profit outlook as demand for weight-loss drugs soarsInvestor's Business Daily107d agobullish
Eli Lilly Stock In A Buy Zone, Set To Ride The Peptide WaveInvestor's Business Daily114d agobullish
IPO Stock Of The Week: This Eli Lilly Partner Soars 118% In Three MonthsInsider Monkey115d agobullish
AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli LillyThe Wall Street Journal115d agobullish
Eli Lilly to Buy Psychedelic Firm AtaiBeckley for Initial $2.8 BillionThe Wall Street Journal115d agobullish
🔎 Under the Radar: AtaiBeckley Stock Soars on Eli Lilly DealSimply Wall St.116d agobullish
Eli Lilly (LLY) Wins Full FDA Approval For Retevmo In Broader CancersInvestor's Business Daily125d agobullish
Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into EarningsBloomberg137d agobullish
A $30 Billion Cancer Breakthrough Is Under Threat From Global ConflictsInvestor's Business Daily149d agobullish
Eli Lilly Stock Hits Buy Zone As Earnings Soar 156%. Funds Are Loading Up.Reuters151d agobullish
Lilly stays ahead of the pack as rivals jump on obesity drug bandwagonBloomberg153d agobullishVIDEO
Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers